Level up your trading with our powerful tools and real-time insights all in one place.
The current XBI market cap is 7.45B. The company's latest EPS is USD 9.9073 and P/E is 10.09.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.8M | 35.72M | 11.95M | 18.32M | 25.52M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 1.05B | 1.19B | -3.88B | 733.48M | 739.09M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.26B | 8.09B | 7.44B | 7.08B | 7.45B |
| Total Liabilities | 858.78M | 837.25M | 594.73M | 635.62M | 533.49M |
| Total Equity | 5.4B | 7.25B | 6.84B | 6.45B | 6.92B |
| Market Cap | 7.45B |
| Price to Earnings Ratio | 10.09 |
| Price to Sales Ratio | 292.31 |
| Price to Cash Ratio | 111.11k |
| Price to Book Ratio | 1.08 |
| Dividend Yield | - |
| Shares Outstanding | 74.6M |
| Average Volume (1 week) | 10.32M |
| Average Volume (1 Month) | 10.67M |
| 52 Week Change | 36.08% |
| 52 Week High | 105.47 |
| 52 Week Low | 71.99 |
| Spread (Intraday) | 0.1 (0.1%) |
| Company Name | SPDR S&P Biotech |
| Address |
one iron street boston, massachusetts 02210 |
| Website | https://www.spdrs.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
